Related references
Note: Only part of the references are listed.Is genetic variability in carboxylesterase-1 and carboxylesterase-2 drug metabolism an important component of personalized medicine?
S. Casey Laizure et al.
XENOBIOTICA (2020)
Carboxylesterase 1 and Precision Pharmacotherapy: Pharmacogenetics and Nongenetic Regulators
Lucy Her et al.
DRUG METABOLISM AND DISPOSITION (2020)
1-(3-Tert-Butylphenyl)-2,2,2-Trifluoroethanone as a Potent Transition-State Analogue Slow-Binding Inhibitor of Human Acetylcholinesterase: Kinetic, MD and QM/MM Studies
Irina V. Zueva et al.
BIOMOLECULES (2020)
Metabolism of deltamethrin and cis- and trans-permethrin by human expressed cytochrome P450 and carboxylesterase enzymes
Laura Hedges et al.
XENOBIOTICA (2019)
The Impact of Carboxylesterases in Drug Metabolism and Pharmacokinetics
Li Di
CURRENT DRUG METABOLISM (2019)
Novel regulatory roles of carboxylesterase 3 in lipid metabolism and browning in 3T3-L1 white adipocytes
Sulagna Mukherjee et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2019)
Cholinesterase and carboxylesterase inhibitors as pharmacological agents
G. F. Makhaeva et al.
RUSSIAN CHEMICAL BULLETIN (2019)
Synthesis, molecular docking, and biological evaluation of 3-oxo-2-tolylhydrazinylidene-4,4,4-trifluorobutanoates bearing higher and natural alcohol moieties as new selective carboxylesterase inhibitors
Galina F. Makhaeva et al.
BIOORGANIC CHEMISTRY (2019)
Synthesis of 2-arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoic acids as new selective carboxylesterase inhibitors and radical scavengers
Olga G. Khudina et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Functional Study of Carboxylesterase 1 Protein Isoforms
Xinwen Wang et al.
PROTEOMICS (2019)
Carboxylesterases in lipid metabolism: from mouse to human
Jihong Lian et al.
PROTEIN & CELL (2018)
Carboxylesterase Inhibitors: An Update
Li-Wei Zou et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Clinical implications of genetic variation in carboxylesterase drug metabolism
Feng Chen et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2018)
The expanding role of prodrugs in contemporary drug design and development
Jarkko Rautio et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Human carboxylesterases: a comprehensive review
Dandan Wang et al.
ACTA PHARMACEUTICA SINICA B (2018)
Known Hepatoprotectors Act as Antioxidants and Immune Stimulators in Stressed Mice: Perspectives in Animal Health Care
Gustavo Alberto de la Riva et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Effects of Genetic Variants on Carboxylesterase 1 Gene Expression, and Clopidogrel Pharmacokinetics and Antiplatelet Effects
Mikko Neuvonen et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2018)
Recent progress in the discovery of natural inhibitors against human carboxylesterases
Dan-Dan Wang et al.
FITOTERAPIA (2017)
Selective Inhibitors of Human Liver Carboxylesterase Based on a β-Lapachone Scaffold: Novel Reagents for Reaction Profiling
M. Jason Hatfield et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synthesis, molecular docking, and biological activity of polyfluoroalkyl dihydroazolo[5,1-c][1,2,4]triazines as selective carboxylesterase inhibitors
Evgeny V. Shchegol'kov et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Computer-aided estimation of the hERG-mediated cardiotoxicity risk of potential drug components
E. V. Radchenko et al.
DOKLADY BIOCHEMISTRY AND BIOPHYSICS (2017)
Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors
Galina F. Makhaeva et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Esterase profiles of organophosphorus compounds in vitro predict their behavior in vivo
Galina F. Makhaeva et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
Carboxylesterases: General detoxifying enzymes
M. Jason Hatfield et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
Prediction of blood-brain barrier permeability of organic compounds
A. S. Dyabina et al.
DOKLADY BIOCHEMISTRY AND BIOPHYSICS (2016)
Regulations of Xenobiotics and Endobiotics on Carboxylesterases: A Comprehensive Review
Yanjiao Xu et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2016)
Serine Protease Catalysis: A Computational Study of Tetrahedral Intermediates and Inhibitory Adducts
Phong D. Ngo et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2016)
Prediction of human intestinal absorption of drug compounds
E. V. Radchenko et al.
RUSSIAN CHEMICAL BULLETIN (2016)
Molecular polymorphism of human enzymes as the basis of individual sensitivity to drugs. Supercomputer-assisted modeling as a tool for analysis of structural changes and enzymatic activity of proteins
S. D. Varfolomeev et al.
RUSSIAN CHEMICAL BULLETIN (2016)
Alkyl 2-arylhydrazinylidene-3-oxo-3-polyfluoroalkylpropionates as new effective and selective inhibitors of carboxylesterase
N. P. Boltneva et al.
DOKLADY BIOCHEMISTRY AND BIOPHYSICS (2015)
Individualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics
Henrik Berg Rasmussen et al.
PHARMACOGENOMICS (2015)
Mechanically Activated Solid-State Synthesis of Phenylhydrazone Derivatives via High-Speed Ball Milling
Xingyi Zhu et al.
LETTERS IN ORGANIC CHEMISTRY (2014)
integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes
Eduardo Dominguez et al.
NATURE CHEMICAL BIOLOGY (2014)
Sc(OTf)3-Catalyzed Transfer Diazenylation of 1,3-Dicarbonyls with Triazenes via N-N Bond Cleavage
Cong Liu et al.
ORGANIC LETTERS (2014)
Organophosphorus compound esterase profiles as predictors of therapeutic and toxic effects
Galina F. Makhaeva et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2013)
Modulation of Esterified Drug Metabolism by Tanshinones from Salvia miltiorrhiza (Danshen)
M. Jason Hatfield et al.
JOURNAL OF NATURAL PRODUCTS (2013)
The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance?
S. Casey Laizure et al.
PHARMACOTHERAPY (2013)
Synthesis and exploration of QSAR model of 2-methyl-3-[2-(2-methylprop-1-en-1-yl)-1H-benzimidazol-1-yl] pyrimido[1,2-a] benzimidazol-4(3H)-one as potential antibacterial agents
Pratibha Sharma et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2012)
Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important Ligands
Jonah Cheung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Quantifying the chemical beauty of drugs
G. Richard Bickerton et al.
NATURE CHEMISTRY (2012)
Synthesis and biological activity of O-carbamoylated 1,1,1,3,3,3-hexafluoroisopropanols as new specific inhibitors of carboxylesterase
G. R. Mukhamadieva et al.
PHARMACEUTICAL CHEMISTRY JOURNAL (2012)
Organ-specific carboxylesterase profiling identifies the small intestine and kidney as major contributors of activation of the anticancer prodrug CPT-11
M. Jason Hatfield et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Requirements for mammalian carboxylesterase inhibition by substituted ethane-1,2-diones
Elizabeth I. Parkinson et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Synthesis and bio-evaluation of aryl hydrazono esters for oviposition responses in Aedes albopictus
Prabal Bandyopadhyay et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Carboxylesterase inhibitors
M. Jason Hatfield et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2011)
Online chemical modeling environment (OCHEM): web platform for data storage, model development and publishing of chemical information
Iurii Sushko et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2011)
The Role of Intestinal Carboxylesterase in the Oral Absorption of Prodrugs
Teruko Imai et al.
CURRENT DRUG METABOLISM (2010)
Nuclear receptor-mediated regulation of carboxylesterase expression and activity
Jeff L. Staudinger et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)
Prodrug approach using carboxylesterases activity: catalytic properties and gene regulation of carboxylesterase in mammalian tissue
Teruko Imai et al.
JOURNAL OF PESTICIDE SCIENCE (2010)
Carboxylesterases: dual roles in lipid and pesticide metabolism
Matthew K. Ross et al.
JOURNAL OF PESTICIDE SCIENCE (2010)
Recommended nomenclature for five mammalian carboxylesterase gene families: human, mouse, and rat genes and proteins
Roger S. Holmes et al.
MAMMALIAN GENOME (2010)
Carboxylesterases: Structure, Function and Polymorphism
Tetsuo Satoh et al.
BIOMOLECULES & THERAPEUTICS (2009)
Comparison of benzil and trifluoromethyl ketone (TFK)-mediated carboxylesterase inhibition using classical and 3D-quantitative structure-activity relationship analysis
Toshiyuki Harada et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Steric structure of alkyl 2-aryl(hetaryl)hydrazono-3-fluoroalkyl-3-oxopropionates
O. G. Khudina et al.
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY (2009)
Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms
Luis A. Videla
WORLD JOURNAL OF HEPATOLOGY (2009)
Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs
Masakiyo Hosokawa
MOLECULES (2008)
Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1
Janice L. Hyatt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Selective inhibition of carboxylesterases by isatins, indole-2,3-diones
Janice L. Hyatt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Geometric isomerism in the series of fluoroalkyl-containing 1,2,3-trione 2-arylhydrazones
O. G. Khudina et al.
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY (2007)
Analysis of mammalian carboxylesterase inhibition by trifluoromethylketone-containing compounds
Randy M. Wadkins et al.
MOLECULAR PHARMACOLOGY (2007)
Multisite promiscuity in the processing of endogenous substrates by human carboxylesterase 1
Sompop Bencharit et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Structure, function and regulation of carboxylesterases
Tetsuo Satoh et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2006)
Human carboxylesterase isozymes: Catalytic properties and rational drug design
Teruko Imai
DRUG METABOLISM AND PHARMACOKINETICS (2006)
Carboxylesterases - Ddetoxifying enzymes and targets for drug therapy
PM Potter et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Identification and characterization of novel benzil (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterases
RM Wadkins et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Mammalian carboxylesterases: from drug targets to protein therapeutics
MR Redinbo et al.
DRUG DISCOVERY TODAY (2005)
The interaction of fluorinated 2-arylhydrazono-1,3-dicarbonyl compounds with o-phenylenediamine
OG Khudina et al.
JOURNAL OF FLUORINE CHEMISTRY (2004)
Discovery of novel selective inhibitors of human intestinal carboxylesterase for the amelioration of irinotecan-induced diarrhea: Synthesis, quantitative structure-activity relationship analysis, and biological activity
RM Wadkins et al.
MOLECULAR PHARMACOLOGY (2004)
Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products
Y Nicolet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Role of the catalytic triad and oxyanion hole in acetylcholinesterase catalysis: An ab initio QM/MM study
YK Zhang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
1,2-bis(1H-indol-3-yl)ethane-1,2-dione, an indole alkaloid from the marine sponge Smenospongia sp.
MJ McKay et al.
JOURNAL OF NATURAL PRODUCTS (2002)
Synthesis of new carboxylesterase inhibitors and evaluation of potency and water solubility
CE Wheelock et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2001)
Share Paper
